Geron (NasdaqGS:GERN) FY Conference Transcript

Geron (NasdaqGS:GERN) FY Conference March 10, 2026 10:30 AM ET Company ParticipantsHarout Semerjian - President and CEOJoseph Eid - EVP of Research and Development and Chief Medical OfficerConference Call ParticipantsNicole Germino - AnalystNicole GerminoGood morning, everyone. I'm Nicole Germino, one of the biopharma investment bankers here at Barclays, and today we are joined by Harout Semerjian, President and CEO, and Joseph Eid, Executive Vice President of Research and Development and CMO of Geron. Than ...